Literature DB >> 31549879

The Truth Is Unfolding About Transthyretin Cardiac Amyloidosis.

Justin L Grodin1, Mathew S Maurer2.   

Abstract

Entities:  

Keywords:  Editorials; amyloidosis, hereditary; cardiomyopathies; quality of life

Mesh：

Substances：

Year:  2019        PMID： 31549879      PMCID： PMC6761830          DOI： 10.1161/CIRCULATIONAHA.119.041015

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   39.918


× No keyword cloud information.
  14 in total

1.  Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).

Authors:  Frederick L Ruberg; Mathew S Maurer; Daniel P Judge; Steven Zeldenrust; Martha Skinner; Antony Y Kim; Rodney H Falk; Kin N Cheung; Ayan R Patel; Arian Pano; Jeffrey Packman; Donna Roy Grogan
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

2.  Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis.

Authors:  Simone Longhi; Massimiliano Lorenzini; Christian Gagliardi; Agnese Milandri; Antonio Marzocchi; Cinzia Marrozzini; Francesco Saia; Paolo Ortolani; Elena Biagini; Pier Luigi Guidalotti; Ornella Leone; Claudio Rapezzi
Journal:  JACC Cardiovasc Imaging       Date:  2015-07-15

3.  Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.

Authors:  David Adams; Alejandra Gonzalez-Duarte; William D O'Riordan; Chih-Chao Yang; Mitsuharu Ueda; Arnt V Kristen; Ivailo Tournev; Hartmut H Schmidt; Teresa Coelho; John L Berk; Kon-Ping Lin; Giuseppe Vita; Shahram Attarian; Violaine Planté-Bordeneuve; Michelle M Mezei; Josep M Campistol; Juan Buades; Thomas H Brannagan; Byoung J Kim; Jeeyoung Oh; Yesim Parman; Yoshiki Sekijima; Philip N Hawkins; Scott D Solomon; Michael Polydefkis; Peter J Dyck; Pritesh J Gandhi; Sunita Goyal; Jihong Chen; Andrew L Strahs; Saraswathy V Nochur; Marianne T Sweetser; Pushkal P Garg; Akshay K Vaishnaw; Jared A Gollob; Ole B Suhr
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

4.  Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.

Authors:  Merrill D Benson; Márcia Waddington-Cruz; John L Berk; Michael Polydefkis; Peter J Dyck; Annabel K Wang; Violaine Planté-Bordeneuve; Fabio A Barroso; Giampaolo Merlini; Laura Obici; Morton Scheinberg; Thomas H Brannagan; William J Litchy; Carol Whelan; Brian M Drachman; David Adams; Stephen B Heitner; Isabel Conceição; Hartmut H Schmidt; Giuseppe Vita; Josep M Campistol; Josep Gamez; Peter D Gorevic; Edward Gane; Amil M Shah; Scott D Solomon; Brett P Monia; Steven G Hughes; T Jesse Kwoh; Bradley W McEvoy; Shiangtung W Jung; Brenda F Baker; Elizabeth J Ackermann; Morie A Gertz; Teresa Coelho
Journal:  N Engl J Med       Date:  2018-07-05       Impact factor: 91.245

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.

Authors:  Esther González-López; Maria Gallego-Delgado; Gonzalo Guzzo-Merello; F Javier de Haro-Del Moral; Marta Cobo-Marcos; Carolina Robles; Belén Bornstein; Clara Salas; Enrique Lara-Pezzi; Luis Alonso-Pulpon; Pablo Garcia-Pavia
Journal:  Eur Heart J       Date:  2015-07-28       Impact factor: 29.983

7.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

8.  Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).

Authors:  Mathew S Maurer; Mazen Hanna; Martha Grogan; Angela Dispenzieri; Ronald Witteles; Brian Drachman; Daniel P Judge; Daniel J Lenihan; Stephen S Gottlieb; Sanjiv J Shah; D Eric Steidley; Hector Ventura; Srinivas Murali; Marc A Silver; Daniel Jacoby; Savitri Fedson; Scott L Hummel; Arnt V Kristen; Thibaud Damy; Violaine Planté-Bordeneuve; Teresa Coelho; Rajiv Mundayat; Ole B Suhr; Márcia Waddington Cruz; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2016-07-12       Impact factor: 24.094

9.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.

Authors:  Mathew S Maurer; Jeffrey H Schwartz; Balarama Gundapaneni; Perry M Elliott; Giampaolo Merlini; Marcia Waddington-Cruz; Arnt V Kristen; Martha Grogan; Ronald Witteles; Thibaud Damy; Brian M Drachman; Sanjiv J Shah; Mazen Hanna; Daniel P Judge; Alexandra I Barsdorf; Peter Huber; Terrell A Patterson; Steven Riley; Jennifer Schumacher; Michelle Stewart; Marla B Sultan; Claudio Rapezzi
Journal:  N Engl J Med       Date:  2018-08-27       Impact factor: 91.245

10.  Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium.

Authors:  Isabelle Lousada; Raymond L Comenzo; Heather Landau; Spencer Guthrie; Giampaolo Merlini
Journal:  Adv Ther       Date:  2015-10-23       Impact factor: 3.845
View more
  3 in total

1.  Preparative Scale Production of Recombinant Human Transthyretin for Biophysical Studies of Protein-Ligand and Protein-Protein Interactions.

Authors:  Ellen Y Cotrina; Marta Vilà; Joan Nieto; Gemma Arsequell; Antoni Planas
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

Review 2.  Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.

Authors:  Jan M Griffin; Mathew S Maurer
Journal:  Trends Cardiovasc Med       Date:  2019-12-17       Impact factor: 6.677

3.  Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis.

Authors:  Toshihide Izumida; Teruhiko Imamura; Makiko Nakamura; Koichiro Kinugawa
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.